| Literature DB >> 36212266 |
B Borawski1, P Kuca1, G Zieliński2, M Maksymowicz3, P Witek1.
Abstract
Isolated sarcoidosis of the hypothalamic-pituitary system is a very rare form of neurosarcoidosis. A high index of suspicion is required for diagnosis and the choice of therapy embodies another challenge due to lack of standardized protocols. Glucocorticoids are the mainstay of initial treatment, whereas the second and third-line therapy include immunomodulators and cytotoxic drugs, in addition to monoclonal antibodies. This report presents an unusual case of panhypopituitarism in a 32-year-old previously healthy male patient due to isolated hypothalamo-pituitary sarcoidosis confirmed histologically, refractory to pulse-dose glucocorticoids and then successfully treated by methotrexate. Based on our report, in patients requiring additional therapy usage of the methotrexate as the second line agent should be considered, however the time frame and the dosing schedule of methotrexate are still unknown and deserve further investigation. ©2022 Acta Endocrinologica (Buc).Entities:
Keywords: Sarcoidosis; hypothalamus; isolated; methotrexate; neurosarcoidosis; pituitary
Year: 2022 PMID: 36212266 PMCID: PMC9512385 DOI: 10.4183/aeb.2022.244
Source DB: PubMed Journal: Acta Endocrinol (Buchar) ISSN: 1841-0987 Impact factor: 1.104